STARRLOC: Long-term Results of the Stapled Transanal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Recruiting
CT.gov ID
NCT05037422
Collaborator
(none)
77
1
13
5.9

Study Details

Study Description

Brief Summary

Rectal static disorders, including the rectocele, represent a frequent functional pathology which affects the quality of life of affected patients. Among vaginal treatments, the STARR technique corresponds to rectal resection by transanal approach using a stapler. The American Gastroenterology Association (AGA) has concluded that service to patients is insufficient. The technical and functional results published are mostly short-term studies. The investigators seek to assess the technical and functional results of Operation STARR, based on a series of consecutive expert center cases, to confirm or refute the conclusions of the AGA recommendations.

Condition or Disease Intervention/Treatment Phase
  • Procedure: STARR surgery

Study Design

Study Type:
Observational
Anticipated Enrollment :
77 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Single-center Retrospective Study of the Long-term Results of the Stapled TransAnal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele in Consecutive Patients
Actual Study Start Date :
Oct 16, 2021
Anticipated Primary Completion Date :
Oct 16, 2022
Anticipated Study Completion Date :
Nov 16, 2022

Outcome Measures

Primary Outcome Measures

  1. Long term results of the STARR operation. [10 years]

    Dyschezia postoperatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Inclusion Criteria:
  • Patient operated for rectocele for 10 or more

  • Age 18 and over

  • Informed patients

Exclusion Criteria:
  • Patient objection

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Grenoble Alpes, Service de chirurgie digestive et de l'urgence Grenoble France

Sponsors and Collaborators

  • University Hospital, Grenoble

Investigators

  • Principal Investigator: Jean-Luc Faucheron, MD, CHU Grenoble Alpes

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT05037422
Other Study ID Numbers:
  • 38RC21.144
First Posted:
Sep 8, 2021
Last Update Posted:
Jun 2, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2022